Functional expression and localization of P‐glycoprotein at the blood brain barrier

No abstract is available for this paper.

• Publication year

  2002

• Venue

  Microscopy research and technique (Print)

• Publication date

  2002-06-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1002/jemt.10090PMID 12112443
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Transcytosis of macromolecules through the blood-brain barrier: a cell biological perspective and critical appraisal

  2004cited by this paper
• Conditionally immortalized cell lines as a new in vitro model for the study of barrier functions.

  2001cited by this paper
• Transport of choline and its relationship to the expression of the organic cation transporters in a rat brain microvessel endothelial cell line (RBE4).

  2001influential reference
• Functional expression of P-glycoprotein in rat brain microglia.

  2001influential reference
• Neurotrophic and neuroprotective actions of estrogens and their therapeutic implications.

  2001cited by this paper
• Phospholipid flippase activity of the reconstituted P-glycoprotein multidrug transporter.

  2001cited by this paper
• Drug transporters in the central nervous system: brain barriers and brain parenchyma considerations.

  2001cited by this paper
• Establishment and functional characterization of an in vitro model of the blood-brain barrier, comprising a co-culture of brain capillary endothelial cells and astrocytes.

  2001cited by this paper
• The disposition of saquinavir in normal and P-glycoprotein deficient mice, rats, and in cultured cells.

  2000cited by this paper
• Pharmacological inhibition of P-glycoprotein transport enhances the distribution of HIV-1 protease inhibitors into brain and testes.

  2000cited by this paper
• Specific Mechanisms for Transporting Drugs Into Brain

  2000cited by this paper
• Functional expression of p‐glycoprotein and multidrug resistance‐associated protein (mrp1) in primary cultures of rat astrocytes

  2000cited by this paper
• Primary cultures of brain microvessel endothelial cells: a valid and flexible model to study drug transport through the blood-brain barrier in vitro.

  2000cited by this paper
• In Vitro Models of the Blood–Brain Barrier and Their Use in Drug Development

  2000cited by this paper
• mRNA Expression and Transport Characterization of Conditionally Immortalized Rat Brain Capillary Endothelial Cell Lines; a New in vitro BBB Model for Drug Targeting

  2000cited by this paper
• P‐glycoprotein is localized in caveolae in resistant cells and in brain capillaries

  2000cited by this paper
• Xenobiotic transport across isolated brain microvessels studied by confocal microscopy.

  2000influential reference
• Dexamethasone Regulation of P‐Glycoprotein Activity in an Immortalized Rat Brain Endothelial Cell Line, GPNT

  1999cited by this paper
• Modulation of P-glycoprotein function in human lymphocytes and Caco-2 cell monolayers by HIV-1 protease inhibitors.

  1999cited by this paper
• P‐glycoprotein subcellular localization and cell morphotype in MDR1 gene‐transfected human osteosarcoma cells

  1999cited by this paper
• Characterization of transferrin receptor in an immortalized cell line of rat brain endothelial cells, RBE4.

  1999influential reference
• BARRIER MECHANISMS IN THE BRAIN, II. IMMATURE BRAIN

  1999cited by this paper
• Choroid plexus epithelial expression of MDR1 P glycoprotein and multidrug resistance-associated protein contribute to the blood-cerebrospinal-fluid drug-permeability barrier.

  1999cited by this paper
• Role of P-glycoprotein in the renal transport of dideoxynucleoside analog drugs.

  1999influential reference
• Induction of blood-brain barrier properties in immortalized bovine brain endothelial cells by astrocytic factors.

  1999cited by this paper
• P-Glycoprotein on astrocyte foot processes of unfixed isolated human brain capillaries.

  1999cited by this paper
• Cerebral and pial microvessels: differential expression of γ-glutamyl transpeptidase and alkaline phosphatase

  1999cited by this paper
• BARRIER MECHANISMS IN THE BRAIN, I. ADULT BRAIN

  1999cited by this paper
• Interaction of anti-HIV protease inhibitors with the multidrug transporter P-glycoprotein (P-gp) in human cultured cells.

  1998cited by this paper
• Functional intracellular P‐glycoprotein

  1998cited by this paper
• The drug transporter P-glycoprotein limits oral absorption and brain entry of HIV-1 protease inhibitors.

  1998cited by this paper
• The P-Glycoprotein Efflux Pump: How Does it Transport Drugs?

  1998cited by this paper
• Multidrug Resistance‐Related Transport Proteins in Isolated Human Brain Microvessels and in Cells Cultured from These Isolates

  1998cited by this paper
• Mrp1 Multidrug Resistance‐Associated Protein and P‐Glycoprotein Expression in Rat Brain Microvessel Endothelial Cells

  1998influential reference
• Up-regulation of Caveolae and Caveolar Constituents in Multidrug-resistant Cancer Cells*

  1998influential reference
• P-glycoprotein is strongly expressed in the luminal membranes of the endothelium of blood vessels in the brain.

  1997cited by this paper
• The P-Glycoprotein Efflux Pump: How Does it Transport Drugs?

  1997cited by this paper
• Production of pure primary rat cerebral endothelial cell culture: a comparison of different methods.

  1997cited by this paper
• Brain Microvascular and Astrocyte Localization of P‐Glycoprotein

  1997cited by this paper
• Development of immortalized human cerebromicrovascular endothelial cell line as an in vitro model of the human blood–brain barrier

  1997cited by this paper
• The physiological function of drug-transporting P-glycoproteins.

  1997cited by this paper
• Multidrug resistance: molecular mechanisms and clinical relevance

  1997cited by this paper
• Morphological and functional characterization of an in vitro blood-brain barrier model.

  1997cited by this paper
• Glucose transport in immortalized rat brain capillary endothelial cells in vitro: transport activity and GLUT1 expression.

  1997cited by this paper
• Monoclonal antibodies specific for P-glycoprotein

  1997cited by this paper
• Role of P‐170 glycoprotein in colchicine brain uptake

  1997cited by this paper
• Functional Expression of P‐Glycoprotein in an Immortalised Cell Line of Rat Brain Endothelial Cells, RBE4

  1996cited by this paper
• P-glycoprotein in the blood-brain barrier of mice influences the brain penetration and pharmacological activity of many drugs.

  1996cited by this paper
• Transporting therapeutics across the blood-brain barrier.

  1996cited by this paper
• The P-glycoprotein multidrug transporter.

  1996influential reference
• Absence of the mdr1a P-Glycoprotein in mice affects tissue distribution and pharmacokinetics of dexamethasone, digoxin, and cyclosporin A.

  1995cited by this paper
• Human Insulin Receptor Monoclonal Antibody Undergoes High Affinity Binding to Human Brain Capillaries in Vitro and Rapid Transcytosis Through the Blood–Brain Barrier in Vivo in the Primate

  1995cited by this paper
• Modulators of multidrug resistance. Preclinical studies.

  1995cited by this paper
• P-glycoprotein

  1995cited by this paper
• Comparisons of P‐glycoprotein expression in isolated rat brain microvessels and in primary cultures of endothelial cells derived from microvasculature of rat brain, epididymal fat pad and from aorta

  1995cited by this paper
• Colloidal gold post-embedding immunocytochemistry.

  1995cited by this paper
• Nuclear immunolocalization of P-glycoprotein in multidrug-resistant cell lines showing similar mechanisms of doxorubicin distribution.

  1995cited by this paper
• Regulation of gamma‐glutamyl transpeptidase and alkaline phosphatase activities in immortalized rat brain microvessel endothelial cells

  1994influential reference
• Potential mechanisms of the age-related changes in the blood-brain barrier.

  1994cited by this paper
• Expression and function of multidrug resistance P-glycoprotein in a cultured natural killer cell-rich population revealed by MRK16 monoclonal antibody and AHC-52.

  1994cited by this paper
• Disruption of the mouse mdr1a P-glycoprotein gene leads to a deficiency in the blood-brain barrier and to increased sensitivity to drugs.

  1994cited by this paper
• Phosphatidylcholine translocase: a physiological role for the mdr2 gene.

  1994cited by this paper
• Localization of Drug‐Metabolizing Enzyme Activities to Blood‐Brain Interfaces and Circumventricular Organs

  1994cited by this paper
• Biochemistry of multidrug resistance mediated by the multidrug transporter.

  1993cited by this paper
• IntroductionIntroduction: The ABC transporter channel superfamily—an overview

  1993cited by this paper
• Nitric oxide and endothelin secretion by brain microvessel endothelial cells: Regulation by cyclic nucleotides

  1993cited by this paper
• Differential modulation of P-glycoprotein transport by protein kinase inhibition.

  1993cited by this paper
• Detection of P glycoprotein activity on normal and leukemic CD34+ cells.

  1993cited by this paper
• High levels of P-glycoprotein detected in isolated brain capillaries.

  1993cited by this paper
• Glutathione S-transferase isoenzymes in rat brain neurons and glia

  1993cited by this paper
• Classical and novel forms of multidrug resistance and the physiological functions of P-glycoproteins in mammals.

  1993cited by this paper
• Regulation by phorbol ester and protein kinase C inhibitors, and by a protein phosphatase inhibitor (okadaic acid), of P-glycoprotein phosphorylation and relationship to drug accumulation in multidrug-resistant human KB cells.

  1992cited by this paper
• Development and characterisation of a rat brain capillary endothelial culture: towards an in vitro blood-brain barrier.

  1992cited by this paper
• [Functional involvement of P-glycoprotein in blood-brain barrier].

  1992influential reference
• Transport properties of P-glycoprotein in plasma membrane vesicles from multidrug-resistant Chinese hamster ovary cells.

  1992cited by this paper
• Expression and activity of the multidrug resistance P-glycoprotein in human peripheral blood lymphocytes.

  1992cited by this paper
• Functional involvement of P-glycoprotein in blood-brain barrier.

  1992cited by this paper
• P-glycoprotein as the drug efflux pump in primary cultured bovine brain capillary endothelial cells.

  1992cited by this paper
• Transport of digoxin by human P-glycoprotein expressed in a porcine kidney epithelial cell line (LLC-PK1).

  1992cited by this paper
• Is the multidrug transporter a flippase?

  1992cited by this paper
• Selective transport of an anti-transferrin receptor antibody through the blood-brain barrier in vivo.

  1991cited by this paper
• The Susceptibility of Cerebral Endothelial Cells to Astroglial Induction of Blood‐Brain Barrier Enzymes Depends on Their Proliferative State

  1991cited by this paper
• Mapping of phenytoin-inducible cytochrome P450 immunoreactivity in the mouse central nervous system.

  1991cited by this paper
• Culture and characterization of microvascular endothelial cells derived from human brain.

  1991influential reference
• Expression and activity of P-glycoprotein, a multidrug efflux pump, in human hematopoietic stem cells.

  1991cited by this paper
• Specialized Localization of P‐Glycoprotein Recognized by MRK 16 Monoclonal Antibody in Endothelial Cells of the Brain and the Spinal Cord

  1990influential reference
• Choline Uptake by Cerebral Capillary Endothelial Cells in Culture

  1990cited by this paper
• Brain-type glucose transporter (GLUT-1) is selectively localized to the blood-brain barrier. Studies with quantitative western blotting and in situ hybridization.

  1990influential reference
• The three mouse multidrug resistance (mdr) genes are expressed in a tissue-specific manner in normal mouse tissues

  1989cited by this paper
• Structure and expression of the human MDR (P-glycoprotein) gene family

  1989cited by this paper
• Bovine Brain Endothelial Cells Express Tight Junctions and Monoamine Oxidase Activity in Long‐Term Culture

  1989cited by this paper
• Multidrug resistance: molecular biology and clinical relevance.

  1989cited by this paper
• Multidrug-resistance gene (P-glycoprotein) is expressed by endothelial cells at blood-brain barrier sites.

  1989cited by this paper
• Lipid Synthesis by Rat Brain Microvessel Endothelial Cells in Tissue Culture

  1989cited by this paper
• P‐glycoprotein: multidrug‐resistance and a superfamily of membrane‐associated transport proteins

  1989cited by this paper
• Multidrug Resistance: Molecular Biology Clinical Relevance

  1989cited by this paper
• Immunohistochemical localization in normal tissues of different epitopes in the multidrug transport protein P170: evidence for localization in brain capillaries and crossreactivity of one antibody with a muscle protein.

  1989cited by this paper
• Purification of murine endothelial cell cultures by flow cytometry using fluorescein-labeled griffonia simplicifolia agglutinin.

  1989cited by this paper
• Cultured human and canine endothelial cells from brain microvessels.

  1988cited by this paper
• Expression of a full-length cDNA for the human "MDR1" gene confers resistance to colchicine, doxorubicin, and vinblastine.

  1987cited by this paper

• Recent Trends in Nanocarrier-Based Drug Delivery System for Prostate Cancer

  2024cites this paper
• A review on drug interaction

  2024cites this paper
• The association of ABC proteins with multidrug resistance in cancer.

  2024cites this paper
• Antiretroviral drugs efavirenz, dolutegravir and bictegravir dysregulate blood-brain barrier integrity and function

  2023cites this paper
• Impact of Hydrogen Bonding on P-Glycoprotein Efflux Transport as Revealed by Evaluation of a De Novo Prediction Model

  2023cites this paper
• Alcohol, inflammation, and blood-brain barrier function in health and disease across development.

  2022cites this paper
• Simple and efficient protocol to isolate and culture brain microvascular endothelial cells from newborn mice

  2022cites this paper
• Dose-response assessment of cerebral P-glycoprotein inhibition in vivo with [18F]MC225 and PET.

  2022cites this paper
• Similarities and differences in the localization, trafficking, and function of P-glycoprotein in MDR1-EGFP-transduced rat versus human brain capillary endothelial cell lines

  2021cites this paper
• Increasing Intracellular Levels of Iron with Ferric Ammonium Citrate Leads to Reduced P-glycoprotein Expression in Human Immortalised Brain Microvascular Endothelial Cells

  2021cites this paper
• Blood–Brain Barrier Permeability of Methyl- 3,4-dihydroxybenzoate derivative NO.2 for Neurodegenerative Diseases Treatment

  2021cites this paper
• Expression of P-gp in Glioblastoma: What we can Learn from Brain Development.

  2020cites this paper
• Efflux transporters in cancer resistance: Molecular and functional characterization of P-glycoprotein

  2020cites this paper
• Novel Intrinsic Mechanisms of Active Drug Extrusion at the Blood-Brain Barrier: Potential Targets for Enhancing Drug Delivery to the Brain?

  2020cites this paper
• Verapamil and Alzheimer’s Disease: Past, Present, and Future

  2020cites this paper
• Perineuronal Nets and Their Role in Synaptic Homeostasis

  2019influential citation
• Tuning Properties for Blood-Brain Barrier (BBB) Permeation: A Statistics-Based Analysis.

  2019cites this paper
• [Advances in research on the pathogenesis of hydrocephalus].

  2019cites this paper
• Blood-brain barrier receptors and transporters: an insight on their function and how to exploit them through nanotechnology

  2019cites this paper
• Protected rituximab aims at brain metastases

  2019cites this paper
• Neolignans from Red Raspberry ( Rubus idaeus L.) Exhibit Enantioselective Neuroprotective Effects against H2O2-Induced Oxidative Injury in SH-SY5Y Cells.

  2018cites this paper
• A Screening Strategy for Evaluation of Drug Transport across the Blood-Brain Barrier: Application to Catechol-O-methyltransferase Inhibitors, Dopamine β-hydroxylase Inhibitors and Dibenz[b,f]azepine-5-carboxamide Derivatives

  2018cites this paper
• The biological significance of brain barrier mechanisms

  2018cites this paper
• A Conformationally Gated Model of Methadone and Loperamide Transport by P-Glycoprotein.

  2018cites this paper
• Effect of amyloid beta on ATP-binding cassette transporter expression and activity in porcine brain microvascular endothelial cells.

  2018cites this paper
• 18 – Basic Pharmacologic Principles

  2017cites this paper
• Potential role of the Virchow Robin space in the pathogenesis of bacterial meningitis.

  2017cites this paper
• Insights Into the Molecular Mechanism of Triptan Transport by P-glycoprotein.

  2017cites this paper
• Verapamil Blocks Scopolamine Enhancement Effect on Memory Consolidation in Passive Avoidance Task in Rats

  2017cites this paper
• P-glycoprotein (ABCB1) and Oxidative Stress: Focus on Alzheimer's Disease

  2017cites this paper
• PHARMACOKINETIC DRUG-DRUG INTERACTIONS EVALUATION OF MELOXICAM WITH SELECTED CO-PRESCRIBED DRUGS

  2017cites this paper
• 132 – Development of the Blood-Brain Barrier

  2017cites this paper
• Pluronic Nanotechnology for Overcoming Drug Resistance

  2017cites this paper
• 4.30 Nanomaterials for Drug Delivery to the Brain

  2017cites this paper
• Chapter 9 Pluronic Nanotechnology for Overcoming Drug Resistance

  2017cites this paper
• Role and modulation of drug transporters in HIV-1 therapy.

  2016cites this paper
• An In Vitro Model of the Blood-brain Barrier Using Impedance Spectroscopy: A Focus on T Cell-endothelial Cell Interaction.

  2016cites this paper
• A dynamic in vivo-like organotypic blood-brain barrier model to probe metastatic brain tumors

  2016cites this paper
• Expression of ATP-Binding Cassette Transporters B1 and C1 after Severe Traumatic Brain Injury in Humans

  2016cites this paper
• Glucocorticoids modify effects of TGF-β1 on multidrug resistance in the fetal blood-brain barrier

  2016cites this paper
• The Blood-Brain Barrier Permeability of Lignans and Malabaricones from the Seeds of Myristica fragrans in the MDCK-pHaMDR Cell Monolayer Model

  2016cites this paper
• New Concepts of Cerebrospinal Fluid Physiology and Development of Hydrocephalus

  2016cites this paper
• The biological significance of brain barrier mechanisms: help or hindrance in drug delivery to the central nervous system?

  2016cites this paper
• Intranasal delivery of nanoparticle encapsulated tarenflurbil: A potential brain targeting strategy for Alzheimer's disease.

  2016cites this paper
• P-glycoprotein expression and amyloid accumulation in human aging and Alzheimer's disease: preliminary observations.

  2015cites this paper
• Regulation of ABC transporters at the blood–brain barrier

  2015cites this paper
• In vitro models for neurotoxicology research

  2015cites this paper
• In vivo and ex vivo regulation of breast cancer resistant protein (Bcrp) by peroxisome proliferator‐activated receptor alpha (Pparα) at the blood–brain barrier

  2015cites this paper
• Regulation of ABC transporters blood-brain barrier: the good, the bad, and the ugly.

  2015cites this paper
• Development of Lipid Based Nanoparticulate Drug Delivery Systems and Drug Carrier Complexes for Delivery to Brain

  2015cites this paper
• Farmacogenetica dei farmaci antiepilettici

  2014cites this paper
• Role of anti-inflammatory compounds in human immunodeficiency virus-1 glycoprotein120-mediated brain inflammation

  2014cites this paper
• Cell-Culture Models of the Blood–Brain Barrier

  2014cites this paper
• Vascular and extravascular distribution of the ATP-binding cassette transporters ABCB1 and ABCC1 in aged human brain and pituitary.

  2014cites this paper
• ABC transporter regulation by signaling at the blood-brain barrier: relevance to pharmacology.

  2014cites this paper
• Drug Access to the Central Nervous System in Alzheimer’s Disease: Preclinical and Clinical Insights

  2014cites this paper
• A proposed role for efflux transporters in the pathogenesis of hydrocephalus

  2014cites this paper
• Liprosomes loading paclitaxel for brain-targeting delivery by intravenous administration: in vitro characterization and in vivo evaluation.

  2014cites this paper
• Transporters at CNS barrier sites: obstacles or opportunities for drug delivery?

  2014cites this paper
• P-glycoprotein trafficking as a therapeutic target to optimize CNS drug delivery.

  2014cites this paper
• Blood-brain barrier models and their relevance for a successful development of CNS drug delivery systems: a review.

  2014cites this paper
• Role of CNS transporters in the pharmacotherapy of HIV-1 associated neurological disorders.

  2014cites this paper
• Signaling pathways that regulate basal ABC transporter activity at the blood- brain barrier.

  2014cites this paper
• Targeting nanoparticles across the blood-brain barrier with monoclonal antibodies.

  2014cites this paper
• Drug Discovery Methods for Studying Brain Drug Delivery and Distribution

  2014cites this paper
• Management and Mitigation of Human Drug-drug Interaction Risks in the Drug Discovery and Development Phases

  2014cites this paper
• Designing the future of nanomedicine: current barriers to targeted brain therapeutics

  2014cites this paper
• The Blood Brain Barrier (BBB)

  2014cites this paper
• Pharmacogénétique des médicaments antiépileptiques

  2014cites this paper
• ABC Transporters at the Blood–Brain Barrier

  2013cites this paper
• Cortical organotypic slice cultures as a tool to analyze the neurovascular unit in hypoxia/ischemia and hypothermia-induced neuroprotection

  2013cites this paper
• Drug Transporters At Brain Barriers

  2013cites this paper
• Expression of multidrug resistance protein 1 and multidrug resistance-associated protein 1 in peripheral blood lymphocytes amongst children and young adults

  2013cites this paper
• Some substrates of P-glycoprotein targeting β -amyloid clearance by quantitative structure-activity relationship (QSAR)/membrane-interaction (MI)-QSAR analysis

  2013cites this paper
• NSAIDs Modulate Morphine Transport at the Blood-Brain Barrier: A Role for P-glycoprotein

  2013cites this paper
• Role of nuclear receptors in the regulation of drug transporters in the brain.

  2013cites this paper
• Microglial activation decreases retention of the protease inhibitor saquinavir: implications for HIV treatment

  2013cites this paper
• In vivo induction of P‐glycoprotein expression at the mouse blood–brain barrier: an intracerebral microdialysis study

  2013cites this paper
• QSAR Analysis of Purine-Type and Propafenone-Type Substrates of P-Glycoprotein Targeting β-Amyloid Clearance

  2013cites this paper
• “Green” Synthesized and Coated Nanosilver Alters the Membrane Permeability of Barrier (Intestinal, Brain Endothelial) Cells and Stimulates Oxidative Stress Pathways in Neurons

  2013cites this paper
• A brain-vectored angiopep-2 based polymeric micelles for the treatment of intracranial fungal infection.

  2012cites this paper
• Influence of P-glycoprotein on brucine transport at the in vitro blood-brain barrier.

  2012cites this paper
• The transport of antiepileptic drugs by P-glycoprotein.

  2012cites this paper
• Cerebral expression of drug transporters in epilepsy.

  2012cites this paper
• Nanotechnological advances for the delivery of CNS therapeutics.

  2012cites this paper
• In vitro blood-brain barrier models: current and perspective technologies.

  2012cites this paper
• Drug-loaded nanocarriers: passive targeting and crossing of biological barriers.

  2012cites this paper
• Barriers in the developing brain and Neurotoxicology.

  2012cites this paper
• CNS Penetration of Tyrosine Kinase Inhibitors in Mouse Models

  2012cites this paper
• Nanoparticle-based combination therapy toward overcoming drug resistance in cancer.

  2012cites this paper
• Regulation of Breast Cancer Resistant Protein by Peroxisome Proliferator-Activated Receptor α in Human Brain Microvessel Endothelial Cells

  2012cites this paper
• Interactions of antiretroviral protease inhibitors with hepatic transport proteins: Mechanisms of drug-induced liver injury

  2012cites this paper
• Expression of ATP-Binding Cassette Membrane Transporters in Rodent and Human Sertoli Cells: Relevance to the Permeability of Antiretroviral Therapy at the Blood-Testis Barrier

  2012cites this paper
• Regulation of P‐glycoprotein by orphan nuclear receptors in human brain microvessel endothelial cells

  2011cites this paper
• The ABC of the blood-brain barrier - regulation of drug efflux pumps.

  2011cites this paper
• Molecular and functional characterization of P-glycoprotein in vitro.

  2011cites this paper
• Influence of drug transport proteins on the pharmacokinetics and drug interactions of HIV protease inhibitors.

  2011cites this paper
• Effect of bile salts on the transport of morphine-6-glucuronide in rat brain endothelial cells.

  2011cites this paper
• Tissue Distribution and Elimination of [14C]Apixaban in Rats

  2011cites this paper
• Influence of time to achieve substrate distribution equilibrium between brain tissue and blood on quantitation of the blood-brain barrier P-glycoprotein effect.

  2011cites this paper